Sector: Consumer health
MX_LAB
Net debt (table and EV/EBITDA): |short-term borrowings| + |long-term borrowings| + |other financial liabilities| when extracted + |non-controlling interest| when extracted − |cash and equivalents|; amounts in millions of the reporting currency.
Shares: yahoo_fundamentals_timeseries/LABB.MX
Monetary columns are in M MXN, one decimal; scale (K/M/B/T) keeps values readable. For the period (default) shows P&L and cash flow for that row’s reporting window: quarterly amounts when the feed uses quarter-duration facts (typical US 10-Q revenue and income), quarterly cash flows after stripping YTD where only cumulative tags exist, and an implied Q4 on 31 Dec FY rows (P&L: FY minus Q1–Q3; operating / investing cash flow: FY 12m minus 9M YTD to 30 Sep when sourced from SEC builder evidence) so they match 10-Q scale. Some issuers still use cumulative YTD minus the prior row in the same calendar year. As reported shows values stored on each row (e.g. full-year on FY). Balance sheet is always as reported. Source JSON may use millions etc.; conversion uses amounts_unit per row.
| Date | Period | Status | RevenueM MXN | Operating profitM MXN | D&AM MXN | EBITDAM MXN | Net profitM MXN | Operating CFM MXN | Capex + M&AM MXN | AssetsM MXN | EquityM MXN | ROE (annualized) | Net debtM MXN | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | Q1 2026 (3M) | OK | 4190.6 y/y -4.9% | 874.4 y/y -9.0% | 90.7 y/y -6.5% | 965.1 y/y -8.7% | 494.6 y/y -0.8% | -229.2 | -80.8 | 24800.5 y/y 3.0% | 11715.2 y/y 5.5% | 17.2% | 5248.8 | Link |
| 2025-06-30 | Q2 2025 (3M) | OK | 4676.4 y/y — | 1030.6 y/y — | 92.0 y/y — | 1122.7 y/y — | -143.7 y/y — | 660.5 | -12.1 | 24244.5 y/y — | 11235.4 y/y — | 12.7% | -2587.9 | Link |
| 2025-03-31 | Q1 2025 (3M) | OK | 4406.3 y/y — | 960.6 y/y — | 97.0 y/y — | 1057.6 y/y — | 498.7 y/y — | -151.0 | -89.3 | 24080.4 y/y — | 11108.9 y/y — | 18.6% | -2157.0 | Link |
| 2023-03-31 | Q1 2023 (3M) | OK | 4178.2 y/y — | 803.8 y/y — | 0.0 y/y — | 803.8 y/y — | 358.0 y/y — | — | — | 21844.4 y/y — | 10379.4 y/y — | — | 0.0 | Link |
Quarterly values ($ mln)
Year-over-year change
FCF ($ mln)
Net debt / cash ($ mln)
Value the company creates per year, as a % of market cap
Value created per year: -71.0%
| 1. EBITDA growth (latest quarter YoY, annualised) [EBITDA latest qtr − EBITDA year-ago qtr] × annualisation X (2026-03-31 vs 2025-03-31) = (965 − 1 058) × 4.09 | -378 |
| 2. Current EV/EBITDA (LTM) (Market cap + Net debt) ÷ EBITDA (LTM) = (14 129 + 5 249) ÷ 3 949 | 4.9x |
| 3. Target multiple (Current EV/EBITDA + 9) ÷ 2 = (4.9 + 9) ÷ 2 | 7.0x |
| 4. Cash flow (balance method, LTM) Net-debt reduction + dividends + buybacks − equity issuance = -7 406 + 0 + 0 − 0 | -7 406 |
| 5. Value created per year (EBITDA growth × Target multiple + Cash flow − Dilution) ÷ Market cap = (-378 × 7.0 + -7 406) ÷ 14 129 | -71.0% |
Amounts in millions of the reporting currency. EBITDA growth is the latest quarter vs the same quarter a year ago, annualised.
Caveats:
| Date | Per share | Details | Status | Source |
|---|---|---|---|---|
| 2026-06-26 | 0.2 MXN | Ex-dividend: 0.2 MXN per share | Paid | Yahoo Finance (ex-div) |
| 2026-03-30 | 0.2 MXN | Ex-dividend: 0.2 MXN per share | Paid | Yahoo Finance (ex-div) |
| 2025-12-23 | 0.2 MXN | Ex-dividend: 0.2 MXN per share | Paid | Yahoo Finance (ex-div) |
| 2025-09-18 | 0.2 MXN | Ex-dividend: 0.2 MXN per share | Paid | Yahoo Finance (ex-div) |
| 2025-06-30 | 0.2 MXN | Ex-dividend: 0.2 MXN per share | Paid | Yahoo Finance (ex-div) |
| 2025-03-13 | 0.2 MXN | Ex-dividend: 0.2 MXN per share | Paid | Yahoo Finance (ex-div) |
| 2024-12-17 | 0.2 MXN | Ex-dividend: 0.2 MXN per share | Paid | Yahoo Finance (ex-div) |
| 2024-09-13 | 0.2 MXN | Ex-dividend: 0.2 MXN per share | Paid | Yahoo Finance (ex-div) |
| 2024-06-20 | 0.2 MXN | Ex-dividend: 0.2 MXN per share | Paid | Yahoo Finance (ex-div) |
| 2024-03-21 | 0.1961 MXN | Ex-dividend: 0.1961 MXN per share | Paid | Yahoo Finance (ex-div) |
| 2023-12-22 | 0.1961 MXN | Ex-dividend: 0.1961 MXN per share | Paid | Yahoo Finance (ex-div) |
| 2023-09-28 | 0.1961 MXN | Ex-dividend: 0.1961 MXN per share | Paid | Yahoo Finance (ex-div) |
| 2023-06-05 | 0.1961 MXN | Ex-dividend: 0.1961 MXN per share | Paid | Yahoo Finance (ex-div) |
| 2022-11-09 | 0.3817 MXN | Ex-dividend: 0.3817 MXN per share | Paid | Yahoo Finance (ex-div) |
| 2022-06-06 | 0.3817 MXN | Ex-dividend: 0.3817 MXN per share | Paid | Yahoo Finance (ex-div) |
| 2021-12-08 | 0.3817 MXN | Ex-dividend: 0.3817 MXN per share | Paid | Yahoo Finance (ex-div) |
| 2021-12-01 | 0.7634 MXN | Ex-dividend: 0.7634 MXN per share | Paid | Yahoo Finance (ex-div) |
KASE: status follows wording in the news headline (paid vs intends to pay). Yahoo: amounts are cash dividends per share on ex-dividend dates (UTC calendar date). stockscope.uz (UZ): amounts are per share in UZS by publication date (not necessarily ex-div).
Investor reporting (IR): https://inversionistas.genommalab.com/en/investors/
Reporting forms detected in loaded periods: ✓ ✓ ✓ (Balance sheet / Profit or loss (P&L) / Cash flows)
Financial results, valuation multiples (P/E, P/B, EV/EBITDA), profitability and dividend yield of Genomma Lab Internacional (LAB) — from primary filings.
Genomma Lab is a pharmaceutical and consumer-health company focused on OTC drugs, personal care and branded generics in Mexico and abroad.